If side effects persist, your provider may adjust your dosage temporarily
The potential anti-depressant and neuroprotective actions broaden their therapeutic scope
Level of evidence Level I, randomized controlled trials
No claims are made regarding the safety or effectiveness of this compound outside of a controlled research environment
5-Amino-1MQ is not an acute-effect compound there is no same-day kick. Everything below is research-framed and drawn largely from animal-model observations
Furthermore, a prespecified subgroup analysis of HF individuals from the SELECT trial evaluating the effects of semaglutide on cardiovascular outcomes in people with overweight or obesity, which included 2,273 HFpEF and 1,347 HFrEF patients, showed that the therapy was associated with a reduction in the HF composite outcome (cardiovascular death or HF hospitalisation/emergency visit) across LVEF, suggesting that GLP-1 RAs may improve outcomes at least in obese HF patients regardless of diabetes status